# Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)

> **NCT00144560** · NA · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 31 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** MRA(Tocilizumab)

## Key facts

- **NCT ID:** NCT00144560
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2008-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144560, "Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00144560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*